ReviewTherapeutic advances in urology2016

Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases.

Christina Hague et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.